EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2016-07-06

CONVERTIBLE LOAN FROM INTERNATIONAL FINANCE CORPORATION

1720

2016-07-05

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2016

1541

2016-06-03

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2016

1499

2016-05-09

POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 9 MAY 2016

1636

2016-05-04

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2016

1529

2016-04-12

SUBSCRIPTION OF SERIES E PREFERRED SHARES IN AC IMMUNE SA

1613

2016-04-06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2016

1565

2016-03-24

NOTICE OF ANNUAL GENERAL MEETING

1571

2016-03-24

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 9 MAY 2016 (or any adjournment thereof)

1531

2016-03-24

PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING

1509

2016-03-21

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2015

1571

2016-03-08

NOTICE OF BOARD MEETING

1553

2016-03-03

INSIDE INFORMATION DISTRIBUTION AGREEMENT WITH ELEKTRON TECHNOLOGY UK LIMITED

1578

2016-03-03

Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2016

1468

2016-02-02

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2016

1504

2016-01-25

INSIDE INFORMATION - COLLABORATION AND LICENSE AGREEMENT AND PROPOSED SUBSCRIPTION OF SERIES C PREFERRED STOCK AND WARRANTS

1637

2016-01-08

INSIDE INFORMATION - CONVERTIBLE LOAN AGREEMENT

1568

2016-01-06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2015

1600

2015-12-31

Terms of Reference - Audit Committee

1016

2015-12-29

Next Day Disclosure Returns

1636

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT